Note: Ingredients listed on restricted chemical lists
EC/CAS
200-842-0/75-12-7
Name of the chemical
Formamide
Concentration
70 - 90
General Information
Version
1.0
Revision date
2024-05-13
Product name
Seq-DI Formamide v2
1.2.1 Relevant identified uses
Professional use
Emergency telephone
+43 1 406 43 43, +32 70 245 245, +359 2 9154 233, +385 1 234 8342, +420 224 919 293, +420 224 915 402, +45 82 12 12 12, +372 7943 794, +358 800 147 111, +358 9 471 977, 0800 147 111, +33 1 45 42 59 59, +33 4 91 75 25 25, +33 1 40 05 48 48, +49 (0) 228 19240, +49 (0) 761 19240, +49 (0) 551 19240, +30 21 07 79 37 77, +36 80 20 11 99, +36 1 476 6464, +354 543 22 22, +354 543 10 00, +353 1 809 2566, +353 1 809 2166, 02 6610 1029, 06 305 4343, +371 67 04 24 73, +370 (5) 236 20 52, +352 8002 5500, +356 2545 65...
Icons in SDS
Company Information
company name
NimaGen B.V
e-mail address of the competent person responsible for the Safety Data Sheet
info@nimagen.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360D
Hazard statements
Code
Statements
H360D
May damage the unborn child
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
May damage fertility or the unborn child.
2.2 Label elements
Labelling
Hazard pictograms
GHS08 GHS08
Signal word
Danger
Contains
formamide
Hazard statements
H360D - May damage the unborn child.
Precautionary statements
P201 - Obtain special instructions before use. P280 - Wear protective gloves, protective clothing, eye protection. P308+P313 - IF exposed or concerned: Get medical advice/attention. P501 - Dispose of contents and container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal..
Additional information
Restricted to professional users. Labelling according to: exemption for inner packaging where the contents do not exceed 10ml
Hazardous Ingredients
formamide
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of formamide (75-12-7) REACH regulation, in accordance with Annex XIII Substance(s) not meeting the vPvB criteria of formamide (75-12-7) REACH regulation, in accordance with Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component Substance(s) not included in the list established formamide (75-12-7) in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
